Back to Results
First PageMeta Content
Syndromes / Myeloid leukemia / Hematopathology / Transplantation medicine / Azacitidine / Acute myeloid leukemia / Erythropoietin / Lenalidomide / International Prognostic Scoring System / Medicine / Hematology / Myelodysplastic syndrome


Treating and Living with Myelodysplastic Syndromes (MDS) Treating Lower-risk MDS The treatment options for people with lower-risk MDS consist of wait and watch, supportive care, immunosuppressive therapy, and medicines r
Add to Reading List

Document Date: 2014-04-30 11:19:42


Open Document

File Size: 419,27 KB

Share Result on Facebook

Company

EPO / The Patient Education Institute Inc. / /

Event

FDA Phase / /

IndustryTerm

healthcare professional / food / energy / /

MedicalCondition

neutropenia antibiotics / cancer / disease / shortness of breath / Myelodysplastic Syndromes / Keep minor infections / chest pains / neutropenia / thrombocytopenia / fever / pain / bad headache / infection / acute myelogenous leukemia / infections / acute myeloid leukemia / anemia / /

MedicalTreatment

chemo / Red blood cell transfusions / red blood cell transfusion / Platelet transfusions / antibiotics / immunosuppressive therapy / chemotherapy / platelet transfusion / blood transfusions / /

Organization

U.S. Food and Drug Administration / FDA / Patient Education Institute / /

Position

Chronic Illness Counselor / /

Product

cyclosporine / Vidaza / Revlimid / Dacogen / Vidaza® / /

Technology

chemotherapy / transplantation / stem cells / ale / ATG / /

URL

www.X-Plain.com / /

SocialTag